These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 30310538)
21. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy. Li J; Sun X; Fang J; Wang C; Han G; Ren W Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570 [TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B. Mak LY; Wong D; Kuchta A; Hilfiker M; Hamilton A; Chow N; Mao X; Seto WK; Yuen MF Clin Mol Hepatol; 2023 Jan; 29(1):146-162. PubMed ID: 35989092 [TBL] [Abstract][Full Text] [Related]
23. Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells. Aggarwal A; Odorizzi PM; Brodbeck J; van Buuren N; Moon C; Chang S; Adona M; Suthram S; Suri V; Trowe T; Turner S; Marcellin P; Buti M; Gaggar A; Fletcher SP; Diehl L; Feierbach B; Balsitis S JHEP Rep; 2023 Apr; 5(4):100664. PubMed ID: 36908748 [TBL] [Abstract][Full Text] [Related]
24. Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Limothai U; Chuaypen N; Poovorawan K; Chotiyaputta W; Tanwandee T; Poovorawan Y; Tangkijvanich P J Viral Hepat; 2019 Dec; 26(12):1481-1488. PubMed ID: 31446638 [TBL] [Abstract][Full Text] [Related]
25. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes. Lin N; Ye A; Lin J; Liu C; Huang J; Fu Y; Wu S; Xu S; Wang L; Ou Q J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31723011 [TBL] [Abstract][Full Text] [Related]
28. Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection. Larsson SB; Malmström S; Hannoun C; Norkrans G; Lindh M Virol J; 2015 Dec; 12():213. PubMed ID: 26645241 [TBL] [Abstract][Full Text] [Related]
29. Factors and virological significance of hepatitis B virus pregenomic RNA status after 5 years of antiviral therapy. Pan J; Xu J; Luo H; Tan N; Kang Q; Chen H; Cheng R; Han Y; Yang Y; Xu X Int J Infect Dis; 2021 Apr; 105():418-423. PubMed ID: 33676002 [TBL] [Abstract][Full Text] [Related]
30. Characterization of Hepatitis B Precore/Core-Related Antigens. Hong X; Luckenbaugh L; Mendenhall M; Walsh R; Cabuang L; Soppe S; Revill PA; Burdette D; Feierbach B; Delaney W; Hu J J Virol; 2021 Jan; 95(3):. PubMed ID: 33148795 [TBL] [Abstract][Full Text] [Related]
31. Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-alpha-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B. Tangkijvanich P; Komolmit P; Mahachai V; Sa-Nguanmoo P; Theamboonlers A; Poovorawan Y Hepatol Res; 2010 Apr; 40(4):269-77. PubMed ID: 20070399 [TBL] [Abstract][Full Text] [Related]
32. Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Receiving 96-Month Nucleos(t)ide Analog Therapy. Tao Y; Wang M; Liao J; Cheng X; He M; Zhang D; Zhou T; Chen J; Chen E; Tang H Front Med (Lausanne); 2022; 9():787770. PubMed ID: 35295596 [TBL] [Abstract][Full Text] [Related]
33. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy. Liao H; Liu Y; Li X; Wang J; Chen X; Zou J; Li Q; Liu L; Wang J; Huang B; Lu F; Xu D Antivir Ther; 2019; 24(2):105-115. PubMed ID: 30511941 [TBL] [Abstract][Full Text] [Related]
34. Kinetics of serum HBsAg and intrahepatic cccDNA during pegylated interferon therapy in patients with HBeAg-positive and HBeAg-negative chronic hepatitis B. Chuaypen N; Sriprapun M; Praianantathavorn K; Payungporn S; Wisedopas N; Poovorawan Y; Tangkijvanich P J Med Virol; 2017 Jan; 89(1):130-138. PubMed ID: 27307409 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α. Caviglia GP; Abate ML; Noviello D; Olivero A; Rosso C; Troshina G; Ciancio A; Rizzetto M; Saracco GM; Smedile A Hepatol Res; 2017 Jul; 47(8):747-754. PubMed ID: 27577976 [TBL] [Abstract][Full Text] [Related]
36. Serum O-glycosylated hepatitis B surface antigen levels in patients with chronic hepatitis B during nucleos(t)ide analog therapy. Murata A; Angata K; Sogabe M; Sato S; Ichida T; Narimatsu H; Genda T BMC Gastroenterol; 2022 May; 22(1):270. PubMed ID: 35641912 [TBL] [Abstract][Full Text] [Related]
37. [Serum hepatitis B virus pregenomic RNA profiles in patients with chronic hepatitis B on long-term antiviral therapy]. Pan JL; Luo H; Zhang XX; Han YF; Chen HY; Zeng Z; Xu XY Zhonghua Gan Zang Bing Za Zhi; 2024 Jan; 32(1):16-21. PubMed ID: 38320786 [No Abstract] [Full Text] [Related]
38. Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B. Laras A; Papatheodoridi M; Panopoulou E; Papatheodoridis GV; Hadziyannis SJ; Hadziyannis E Virol J; 2022 Jan; 19(1):22. PubMed ID: 35093105 [TBL] [Abstract][Full Text] [Related]
39. The relationship between serum exosome HBV-miR-3 and current virological markers and its dynamics in chronic hepatitis B patients on antiviral treatment. Gan W; Chen X; Wu Z; Zhu X; Liu J; Wang T; Gao Z Ann Transl Med; 2022 May; 10(10):536. PubMed ID: 35722385 [TBL] [Abstract][Full Text] [Related]
40. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels. Rijckborst V; Hansen BE; Cakaloglu Y; Ferenci P; Tabak F; Akdogan M; Simon K; Akarca US; Flisiak R; Verhey E; Van Vuuren AJ; Boucher CA; ter Borg MJ; Janssen HL Hepatology; 2010 Aug; 52(2):454-61. PubMed ID: 20683945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]